Diabetic cardiomyopathy: the search for a unifying hypothesis.

Although diabetes is recognized as a potent and prevalent risk factor for ischemic heart disease, less is known as to whether diabetes causes an altered cardiac phenotype independent of coronary atherosclerosis. Left ventricular systolic and diastolic dysfunction, left ventricular hypertrophy, and alterations in the coronary microcirculation have all been observed, although not consistently, in diabetic cardiomyopathy and are not fully explained by the cellular effects of hyperglycemia alone. The recent recognition that diabetes involves more than abnormal glucose homeostasis provides important new opportunities to examine and understand the impact of complex metabolic disturbances on cardiac structure and function.

[1]  H. Huikuri,et al.  Echocardiographic evaluation of left ventricular response to isometric exercise in young insulin-dependent diabetics , 1986, Acta diabetologia latina.

[2]  C. R. Wilson,et al.  Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. , 2005, American journal of physiology. Endocrinology and metabolism.

[3]  E. Abel,et al.  Akt1 in the cardiovascular system: friend or foe? , 2005, The Journal of clinical investigation.

[4]  A. Bonen,et al.  Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. , 2005, American journal of physiology. Heart and circulatory physiology.

[5]  J. Born,et al.  Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia. , 2005, Metabolism: clinical and experimental.

[6]  A. Marette,et al.  Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. , 2005, Endocrinology.

[7]  J. Huss,et al.  Mitochondrial energy metabolism in heart failure: a question of balance. , 2005, The Journal of clinical investigation.

[8]  G. Condorelli,et al.  Akt Mediates the Cross-Talk Between &bgr;-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes , 2005, Circulation research.

[9]  Xianlin Han,et al.  Transgenic Expression of Fatty Acid Transport Protein 1 in the Heart Causes Lipotoxic Cardiomyopathy , 2005, Circulation research.

[10]  D. Raev Left ventricular function and specific diabetic complications in other target organs in young insulin-dependent diabetics: An echocardiographic study , 2005, Heart and Vessels.

[11]  J. Carvalheira,et al.  Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway , 2005, Diabetologia.

[12]  R. Pop-Busui,et al.  Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. , 2004, Journal of the American College of Cardiology.

[13]  A. Schmermund,et al.  Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine‐stimulated coronary flow response in human subjects , 2004, Clinical endocrinology.

[14]  M. Cooper,et al.  Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. , 2004, American journal of hypertension.

[15]  V. Rajapurohitam,et al.  Rat heart is a site of leptin production and action. , 2004, American journal of physiology. Heart and circulatory physiology.

[16]  B. Manning Balancing Akt with S6K , 2004, The Journal of cell biology.

[17]  B. Draznin,et al.  Molecular mechanisms of insulin resistance that impact cardiovascular biology. , 2004, Diabetes.

[18]  T. Hunter,et al.  Inappropriate Activation of the TSC/Rheb/mTOR/S6K Cassette Induces IRS1/2 Depletion, Insulin Resistance, and Cell Survival Deficiencies , 2004, Current Biology.

[19]  G. Grassi Counteracting the sympathetic nervous system in essential hypertension , 2004, Current opinion in nephrology and hypertension.

[20]  R. Cooksey,et al.  Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. , 2004, Diabetes.

[21]  C. Yosefy,et al.  Rosiglitazone Improves, While Glibenclamide Worsens Blood Pressure Control in Treated Hypertensive Diabetic and Dyslipidemic Subjects via Modulation of Insulin Resistance and Sympathetic Activity , 2004, Journal of cardiovascular pharmacology.

[22]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[23]  Ernest Adeghate,et al.  Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review , 2004, Molecular and Cellular Biochemistry.

[24]  A. Avogaro,et al.  Early myocardial dysfunction in the diabetic heart: current research and clinical applications. , 2004, The American journal of cardiology.

[25]  A. Avogaro,et al.  Diabetic cardiomyopathy: a metabolic perspective. , 2004, The American journal of cardiology.

[26]  P. Bruneval,et al.  High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[27]  Ren-Ke Li,et al.  Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. , 2004, Endocrinology.

[28]  A. Lochner,et al.  The effects of insulin and β-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats , 2001, Molecular and Cellular Biochemistry.

[29]  A. Luchner,et al.  Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[30]  M. Karmazyn,et al.  Heme oxygenase in diabetes-induced oxidative stress in the heart. , 2003, Journal of molecular and cellular cardiology.

[31]  E. Schwammenthal,et al.  Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus , 2003, Cardiovascular diabetology.

[32]  M. Fukuda,et al.  Diabetes and the Accompanying Hyperglycemia Impairs Cardiomyocyte Calcium Cycling through Increased Nuclear O-GlcNAcylation* , 2003, Journal of Biological Chemistry.

[33]  R. Ramasamy Aldose reductase: a novel target for cardioprotective interventions. , 2003, Current drug targets.

[34]  A. Criollo,et al.  Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis , 2003, Journal of Biological Chemistry.

[35]  A. Bertoni,et al.  Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. , 2003, Diabetes care.

[36]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[37]  E. Abel,et al.  Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. , 2003, American journal of physiology. Heart and circulatory physiology.

[38]  L. Kirshenbaum,et al.  The Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes , 2003, Circulation research.

[39]  E. Picano Diabetic cardiomyopathy. the importance of being earliest. , 2003, Journal of the American College of Cardiology.

[40]  W. Merkle,et al.  Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil , 2003, Cardiovascular diabetology.

[41]  Mu Wang,et al.  Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. , 2003, Diabetes.

[42]  Merlin C. Thomas,et al.  A Breaker of Advanced Glycation End Products Attenuates Diabetes‐Induced Myocardial Structural Changes , 2003, Circulation research.

[43]  P. McNulty Insulin resistance and cardiac mass: the end of the beginning? , 2003, Obesity research.

[44]  F. Leonetti,et al.  Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. , 2003, Obesity research.

[45]  Andrew D McCulloch,et al.  Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy. , 2003, American journal of physiology. Heart and circulatory physiology.

[46]  Y. Sugisaki,et al.  Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. , 2003, Experimental and molecular pathology.

[47]  D. Levy,et al.  Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study , 2003, Circulation.

[48]  S. Yuan,et al.  Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. , 2003, Physiological genomics.

[49]  J. Hare,et al.  Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice , 2002, Circulation.

[50]  M. Kohno,et al.  Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats. , 2002, Cardiovascular research.

[51]  J. R. Wu-wong,et al.  Endothelin-stimulated glucose uptake: effects of intracellular Ca(2+), cAMP and glucosamine. , 2002, Clinical science.

[52]  G. Lopaschuk,et al.  Leptin Activates Cardiac Fatty Acid Oxidation Independent of Changes in the AMP-activated Protein Kinase-Acetyl-CoA Carboxylase-Malonyl-CoA Axis* , 2002, The Journal of Biological Chemistry.

[53]  P. Razeghi,et al.  Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. , 2002, Diabetes.

[54]  J. Chatham,et al.  Cardiac carbohydrate metabolism in Zucker diabetic fatty rats. , 2002, Cardiovascular research.

[55]  B. Howard,et al.  Associations of insulin levels with left ventricular structure and function in American Indians: the strong heart study. , 2002, Diabetes.

[56]  K. Clarke,et al.  Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. , 2002, Diabetes.

[57]  阿部 毅寿 Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats , 2002 .

[58]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[59]  B. Hemmings,et al.  Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.

[60]  A. Marette,et al.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.

[61]  J. Robbins,et al.  The Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and Survival* , 2001, The Journal of Biological Chemistry.

[62]  M. Birnbaum Turning down insulin signaling. , 2001, The Journal of clinical investigation.

[63]  D R Alessi,et al.  PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.

[64]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[65]  A. Clerk,et al.  Akt like a woman: gender differences in susceptibility to cardiovascular disease. , 2001, Circulation research.

[66]  Mark A Sussman,et al.  Myocardial Akt Activation and Gender: Increased Nuclear Activity in Females Versus Males , 2001, Circulation research.

[67]  Gongxin Liu,et al.  Long-Chain Acyl-Coenzyme A Esters and Fatty Acids Directly Link Metabolism to KATP Channels in the Heart , 2001, Circulation research.

[68]  Roy Taylor,et al.  Effects of Tumor Necrosis Factor-α on Insulin Action in Cultured Human Muscle Cells , 2001 .

[69]  R. Fryer,et al.  Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats , 2001, Basic Research in Cardiology.

[70]  G. Francis,et al.  Diabetic cardiomyopathy: fact or fiction? , 2001, Heart.

[71]  J. Gardin,et al.  Importance of heart failure with preserved systolic function in patients ≥65 years of age , 2001 .

[72]  J. Gardin,et al.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. , 2001, The American journal of cardiology.

[73]  J. Mccormack,et al.  Effects of tumor necrosis factor-alpha on insulin action in cultured human muscle cells. , 2001, Diabetes.

[74]  L. Orci,et al.  Lipotoxic diseases of nonadipose tissues in obesity , 2000, International Journal of Obesity.

[75]  D. Severson,et al.  Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. , 2000, American journal of physiology. Endocrinology and metabolism.

[76]  J. Sowers,et al.  Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. , 2000, American journal of physiology. Heart and circulatory physiology.

[77]  T. Nishikawa,et al.  The missing link: a single unifying mechanism for diabetic complications. , 2000, Kidney international. Supplement.

[78]  L. Mansi,et al.  Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. , 2000, Journal of the American College of Cardiology.

[79]  K. Ohtomo,et al.  Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[80]  P. McDonagh,et al.  Microvascular Perfusion and Transport in the Diabetic Heart , 2000, Microcirculation.

[81]  H. Taegtmeyer,et al.  Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. , 2000, Journal of molecular and cellular cardiology.

[82]  G. Condorelli,et al.  The Akt-Glycogen Synthase Kinase 3β Pathway Regulates Transcription of Atrial Natriuretic Factor Induced by β-Adrenergic Receptor Stimulation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.

[83]  Simon Stewart,et al.  Epidemiology, aetiology, and prognosis of heart failure , 2000, Heart.

[84]  Y. Kaneda,et al.  Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.

[85]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[86]  G. Paolisso,et al.  Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. , 1999, Hypertension.

[87]  G. King,et al.  Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.

[88]  G. King,et al.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[89]  B. Rodrigues,et al.  Myocardial substrate metabolism: implications for diabetic cardiomyopathy. , 1995, Journal of molecular and cellular cardiology.

[90]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[91]  H. Reinauer,et al.  Different types of postinsulin receptor defects contribute to insulin resistance in hearts of obese Zucker rats. , 1986, Endocrinology.

[92]  J. McNeill,et al.  Diabetes-induced abnormalities in the myocardium. , 1986, Life sciences.

[93]  J. McNeill,et al.  A Functional and Ultrastructural Analysis of Experimental Diabetic Rat Myocardium: Manifestation of a Cardiomyopathy , 1985, Diabetes.

[94]  N. Dhalla,et al.  Pathogenesis of cardiac dysfunction in diabetes mellitus. , 1985, The Canadian journal of cardiology.

[95]  C. F. Pilati,et al.  Left ventricular function of the isolated, genetically obese rat's heart. , 1985, The American journal of physiology.

[96]  J. McNeill,et al.  The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance. , 1982, Canadian journal of physiology and pharmacology.

[97]  E. Sonnenblick,et al.  The Effect of Streptozotocin‐Induced Diabetes in Rats on Cardiac Contractile Proteins , 1981, Circulation research.

[98]  E. Sonnenblick,et al.  Reversibility of Diabetic Cardiomyopathy with Insulin in Rats , 1981, Circulation research.

[99]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.